Filing method-of-use patents tied to specific patient subpopulations, biomarker-defined indications, or combination regimens creates a layered IP estate that complicates any Paragraph IV challenge and preserves PBM negotiating leverage throughout the exclusivity lifecycle
"The GLP-1 Insurance Checker makes it easy for patients to find out what their insurance policy covers at the beginning of their journey, for free, so they can determine the best next step for them." By entering basic insurance information through the online tool, anyone can get a personalized report detailing coverage, cost, and drug supply information across multiple GLP-1 medications
Furthermore, patients with diabetes and obesity experience higher baseline rates of depression and anxiety compared to the general population, independent of medication use
In der Realitt aber zeigt die Einnahme nur selten zufriedenstellende Resultate
PubMed Vinceti, M., Wei, E
We don't have clinical trials for endometriosis